EGFR-TKI-sensitive mutations in lung carcinomas: are they related to clinical features and CT findings?

Qin, Xiaoyi; Gu, Xiaolong; Lu, Yingru; Zhou, Wei

Qin, Xiaoyi; Gu, Xiaolong; Lu, Yingru; Zhou, Wei.

Afiliação

Qin X; Department of Hematology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
Gu X; Department of Pneumology, Ningbo Yinzhou No. 2 Hospital, Ningbo, Zhejiang, People's Republic of China.
Lu Y; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China, wyyyzw@yahoo.com.
Zhou W; Department of Intensive Care Unit, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China, wyyyzw@yahoo.com.

Cancer Manag Res ; 10: 4019-4027, 2018.

Article em En | MEDLINE | ID: mdl-30323660

Palavras-chave

chest computed tomography; epidermal growth factor receptor; ground-glass opacity; lung carcinomas; mutations

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Cancer Manag Res Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google